Volume 2 Supplement 1

ESICM LIVES 2014

Open Access

0859. Altered expression of the bone morphogenetic antagonists in the bleomycin model of acute lung injury

  • N Murphy1, 2,
  • S Coyle Rowan3,
  • S Frohlich2, 4 and
  • P McLoughlin1
Intensive Care Medicine Experimental20142(Suppl 1):P64

https://doi.org/10.1186/2197-425X-2-S1-P64

Published: 26 September 2014

Introduction

Acute lung injury (ALI) is a devastating clinical condition, characterised by acute inflammation that often proceeds to overt pulmonary fibrosis. Basal bone morphogenetic protein (BMP) signalling is essential for normal pulmonary homeostasis. The BMP antagonist gremlin has previously been shown to be increased in hypoxic lung disease, reduce BMP signalling and thus contribute directly to lung damage [1]. BMP antagonsists also play important roles in fibrotic diseases [2].

Objectives

The aim of this study was to investigate the expresison of BMP accessory proteins in an animal model of ALI and assess any associated changes in BMP signalling.

Methods

Acute lung injury was induced in adult mice by intra-tracheal instillation of bleomycin (1U/kg); saline was instilled in control animals. Fourteen days post inoculation, animals were anaesthetised, killed and their lungs removed and snap frozen for later analysis of RNA and protein. Lungs from separate groups were isolated, fixed, and wax embedded for histological and immunohistochemical analysis.

Results

Bleomycin treated lungs showed characteristic structural changes and patchy inflammation. Gremlin, follistatin, follistatin like 1, follistatin like 3, BMPER and noggin mRNA expression was increased, the expression of BAMBI and NOV was reduced. MGP, KCP, lefty and chordin were unchanged. Expresion of Follistatin like 1, BAMBI and noggin protein was increased. Consistent with attentuated BMP signalling, BMP-2 and phospho-smad 1/5/8 was reduced.

Conclusions

These data demonstrate that BMP antagonists are altered in bleomycin injured lungs and associated with reduced BMP signalling.

Declarations

Grant acknowledgment

St Vincent´s Anaesthesia Foundation, St. Vincent´s University Hospital, Dublin 4, Ireland

Authors’ Affiliations

(1)
School of Medicine and Medical Sciences, University College Dublin
(2)
Anaesthesia and Intensive Care Medicine, St Vincent's Hospital
(3)
School of Medicine and Medical Sciences, University college Dublin
(4)
School of Medicine and Medical Sciences, University College Dublin

References

  1. Cahill E, Costello CM, Rowan SC, Harkin S, Howell K, Leonard MO, Southwood M, Cummins EP, Fitzpatrick SF, Taylor CT, Morrell NW, Martin F, Mcloughlin P: Gremlin plays a key role in the pathogenesis of pulmonary hypertension. Circulation 2012, 125: 920–30. 10.1161/CIRCULATIONAHA.111.038125PubMedView ArticleGoogle Scholar
  2. Koli K, Myllarniemi M, Vuorinen K, Salmenkivi K, Ryynanen MJ, Kinnula VL, Keski-Oja J: Bone morphogenetic protein-4 inhibitor gremlin is overexpressed in idiopathic pulmonary fibrosis. The American journal of pathology 2006, 169: 61–71. 10.2353/ajpath.2006.051263PubMed CentralPubMedView ArticleGoogle Scholar

Copyright

© Murphy et al; licensee Springer. 2014

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Advertisement